Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.

Saved in:
Bibliographic Details
Title: Inhibiting geranylgeranyl diphosphate synthesis reduces nuclear androgen receptor signaling and neuroendocrine differentiation in prostate cancer cell models.
Authors: Weissenrieder JS; Departments of Medicine and Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania., Reilly JE; Department of Pharmacology, University of Iowa, Iowa City, Iowa., Neighbors JD; Department of Pharmacology and Medicine Penn State College of Medicine, Hershey, Pennsylvania., Hohl RJ; Departments of Medicine and Pharmacology, Penn State College of Medicine, Hershey, Pennsylvania.
Source: The Prostate [Prostate] 2019 Jan; Vol. 79 (1), pp. 21-30. Date of Electronic Publication: 2018 Aug 14.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8101368 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0045 (Electronic) Linking ISSN: 02704137 NLM ISO Abbreviation: Prostate Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1097-0045
DOI:10.1002/pros.23707